Send feedback

ECE2 p.Ser400=

c.1200C>T · rs150617960 · VCV771357

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
low-frequency (popmax 3.6%, amr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.4GERP 1.6, phastCons 1
Overall
CADD10.57PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 3.6% Admixed American · 2,161/60,014 alleles
Filtering AF 3.47% ClinGen BA1/BS1 input FAF95, joint · FAF99 3.42%
Overall 0.155% 2,510/1,614,188 alleles · low-frequency
Ancestry group Frequency 1 in
Admixed Americangrpmax 3.6% 28
East Asian 0.307% 325
Remaining individualsnot grpmax-eligible 0.213% 470
African / African-American 0.0466% 2,144
South Asian 0.00768% 13,013
European (non-Finnish) 0.00305% 32,779

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ECE2
Protein
p.Ser400=
Coding
c.1200C>T
MANE Select
NM_001100121
dbSNP
rs150617960
Type
single nucleotide variant
Location
chr3:184285529 (GRCh38)
Gene constraint
LOEUF 0.965 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 87.75
Residue 400
a disulfide bond; the peptidase m13 domain
Full ECE2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ece2-p-ser400 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown